Pharmaceutical products for use in oncology; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of prostate cancer; androgen biosynthesis inhibitors for use in oncology; androgen biosynthesis inhibitors for the treatment of cancer; androgen biosynthesis inhibitors for the treatment of prostate cancer; pharmaceutical products affecting hormone levels for medical purposes
Pharmaceuticals